Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07387380 · ClinicalTrials.gov registry record · NA
KIRA Uterine Drain Device Evaluation- First-In- Human Study
A NA study of Cesarean Delivery Procedures, sponsored by Lucie Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07387380: Recruiting NA study of Cesarean Delivery Procedures, sponsored by Lucie Medical.
NCT07387380 is a NA study of Cesarean Delivery Procedures that is actively recruiting participants, run by Lucie Medical. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07387380, a NA study of Cesarean Delivery Procedures, is actively recruiting participants, sponsored by Lucie Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate a new investigational medical device, the Kira device, intended to make it easier for the surgical team to monitor blood loss during and immediately after cesarean deliveries (c-sections). This study will assess the safety of the device and the device's ability to gently suction blood from the uterus into a clear container where it can be seen and measured by the surgical team.
Conditions Studied
Interventions
- DEVICE Uterine drain for use in cesarean section
Study Locations (1)
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07387380 shows while recruiting
NCT07387380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cesarean Delivery Procedures appearing as the primary indexed condition, and to 1 intervention - of which Uterine drain for use in cesarean section is the first listed.
NCT07387380 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07387380 about?
NCT07387380 is a clinical study titled "KIRA Uterine Drain Device Evaluation- First-In- Human Study". The purpose of this research is to evaluate a new investigational medical device, the Kira device, intended to make it easier for the surgical team to monitor blood loss during and immediately after cesarean deliveries (c-sections). This study will assess the safety of the device and the device's ab...
What is the current status of trial NCT07387380?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-01-06. Estimated completion is 2026-06.
What conditions does trial NCT07387380 study?
This clinical trial studies the following conditions: Cesarean Delivery Procedures.
What interventions are being tested in trial NCT07387380?
The interventions under investigation include: Uterine drain for use in cesarean section (DEVICE).
Who is sponsoring clinical trial NCT07387380?
This trial is sponsored by Lucie Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07387380 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07387380's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI